名为LIBERATE-1的试验正在澳大利亚进行，标志着Vivani专有NanoPortal™药物植入技术的首次应用。该试验旨在评估exenatide植入剂在超重或肥胖参与者中的安全性、耐受性和药代动力学特征，以体重变化作为主要衡量指标。

According to the report, battlegroup Center made Ukraine suffer roughly 610 casualties and lose two tanks in the Donetsk People’s Republic ...

The NHRC says those compelling Wole Soyinka and Femi Falana to lead a protest against economic hardship lack a sense of ...

Defense Minister Yaşar Güler says they have faith in Syrian National Army (SNA) to liberate territories occupied by the ...

By Greg McQuade Click here for updates on this story RICHMOND, Virginia (WTVR) — As a journalist for WTVR, I’ve shared the stories of people all across Central Virginia. But for this assignment, I ...